Clinical Trial

Evaluate the Pharmacokinetic Interaction and the Safety of AD-2321 and AD-2322

Name: Evaluate the Pharmacokinetic Interaction and the Safety of AD-2321 and AD-2322 — clinical trial record (NCT07312799)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Record status

This record was last updated December 31, 2025 (before its estimated February 11, 2026 completion). Its status may not reflect the trial's current state.

Summary

To evaluate the pharmacokinetic interactions of AD-2321, AD-2322 in healthy adult volunteers.

Trial Details

NCT Number	NCT07312799
Lead Sponsor	Addpharma Inc.
Conditions	Hypertension
Enrollment	41 participants
Start Date	2026-01-27
Primary Completion	2026-02-11 (estimated)
Study Completion	2026-02-26 (estimated)
Updated on ClinicalTrials.gov	2025-12-31